Scholars Central

Research articlePublished 2018

Is Dual-Time-Point Imaging Necessary for Discrimination of Adrenal Benign Lesions Versus Malignant Masses: A Study Comparing Standard Methods with Dual-Time-Point FDG PET-CT Imaging

Authors: Pelin Ozcan Kara, Zehra Pinar KOC, Taylan Kara, Bugra Kaya, Tamer Aksoy

Chemotherapy: Open Access

Volume 7 · Issue 2 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objectives: This retrospective study was designed to investigate the clinical role of FDG PET-CT, for the evaluation of adrenal lesions and to compare the standart methods with dual-time-point imaging (DTPI) method to distinguish benign from malignant lesions in various cancer patients. Materials and methods: A total of 60 patients with confirmed primary malignancies underwent PET-CT examinations. Of the 60 patients, 79 adrenal lesions (36 benign and 43 malignant adrenal lesions) were shown by CT. Patients were grouped as benign adrenal group (I), malignant adrenal group (II) and dual-phase-group (III). Results: A total of 20 (33%) patients were included in benign adrenal group (Group I) with 28 adrenal lesions. Mean SUVmax value 2.95 were evaluated. All adrenal lesions in Group I had SUVmax value below cut-off 4.2 except 2. A total of 19 (32%) patients were included in malignant adrenal group (Group II) with 22 adrenal lesions. Mean SUVmax value 8.16 were evaluated. All adrenal lesions in Group II had SUVmax value over cut-off 4.2 except 2. A total of 21 (35%) patients were included in dual phase adrenal group (Group III) with 29 adrenal lesions.For malignant adrenal lesions in group III, all of the 21 malign lesions showed increased FDG uptake and SUVmax value in late imaging. Conclusion: Dual time point imaging of PET-CT seems to be very effective especially in adrenal lesions, addition of dual phase study routinely is not necessary and recommented in only indeterminated lesions.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalChemotherapy: Open Access
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Pelin Ozcan Kara”
  • BylineArticles whose byline prints “Zehra Pinar KOC”
  • BylineArticles whose byline prints “Taylan Kara”
  • BylineArticles whose byline prints “Bugra Kaya”
  • BylineArticles whose byline prints “Tamer Aksoy”